Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingWPS 3D Imaging Rendering Coverage Update | OpenPay…
    Ask Trek AI about this page
    CurrentWPS Health InsurancePolicy PUM 250-0045-1812

    3D Rendering on CT/MRI/US Medical Guideline

    Customize your policy alerts

    Sign up for WPS Health Insurance Policy PUM 250-0045-1812 alerts

    Get alerted when Policy PUM 250-0045-1812 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This guideline governs when 3D image rendering or reconstruction is medically necessary for CT, MRI, ultrasound, and specified related imaging applications. Coverage varies by member plan and remains subject to the applicable benefit document, exclusions, authorization requirements, and state or federal law.

    Policy Summary
    PayerWPS Health Insurance
    Policy3D Rendering on CT/MRI/US Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateJuly 1, 2026
    Last ReviewApr 1, 2026
    Next Review DateNot specified
    Key ActionReview the member's contract and endorsements to determine whether prior authorization or other benefit requirements apply.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    6Covered indication categories listed
    2DTraditional imaging alternative
    3D/4D/5DObstetrical ultrasound rendering excluded
    13+Rendering inherent to another service

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    General Coverage Criteria

    Indications of Coverage

    3D rendering is considered medically necessary on CT, MRI, or ultrasound when at least one of the following criteria is met.

    Covered indications

    • Musculoskeletal conditions

      • Congenital skull abnormalities: Evaluation of congenital skull abnormalities in newborns, infants, or toddlers, usually for preoperative planning.
      • Complex joint or pelvic fractures: Evaluation of complex joint fractures or pelvic fractures.
      • Spine fractures: Evaluation of spine fractures, usually for preoperative planning.
      • Complex facial fractures: Evaluation of complex facial fractures.
    • Preoperative planning for other complex surgical cases.
    • Cerebral angiography, except MRA and/or CTA, which are subject to the stated limitations.
    • Echocardiography

      • Valvular disease evaluation: Evaluation of at least moderate valvular stenosis or regurgitation.at least moderate
      • Transcatheter procedure guidance: Guidance of transcatheter valve replacement, mitral valve clipping or replacement, or fistula coiling.

        Examples include TAVR.

      • LV volume and EF assessment: Assessment of left ventricular volume and ejection fraction before ICD implantation, or before or within 12 months after potentially cardiotoxic chemotherapy.before or within 12 months after chemotherapy
    • Ultrasound of pelvic conditions

      • Uterine intra-cavity lesion: Initial ultrasound is equivocal, or 3D ultrasound/sonohysterogram is performed instead of hysteroscopy.
      • Hydrosalpinx or peritoneal cyst: Initial ultrasound is indeterminate, or 3D ultrasound/sonohysterogram is performed instead of hysteroscopy.
      • Lost IUD: The IUD string cannot be felt or seen and the initial ultrasound is indeterminate.
      • Uterine anomaly: Initial ultrasound is indeterminate or equivocal.
      • Infertility evaluation: Initial ultrasound is indeterminate or equivocal, or 3D ultrasound/sonohysterogram is performed instead of hysteroscopy.
    • Abdominal condition: MRCP is performed for assessment of the biliary tree.

      MRCP means magnetic resonance cholangiopancreatography.

    3D image rendering is not medically necessary when the information can be obtained through traditional 2D imaging, such as ultrasound, CT, or MRI, or when it is performed with an imaging study that is itself not medically necessary or investigational.

    Under generally accepted coding guidelines, 3D rendering should not be submitted separately with computer-aided detection, MRA, CTA, nuclear medicine SPECT, PET, PET/CT, mammography, breast MRI, breast ultrasound, breast tomosynthesis, CT colonography, cardiac MRI, cardiac CT, coronary CTA, bronchoscopy, nuclear medicine thyroid uptake, physician-planned patient-specific aortic endograft procedures, or unlisted diagnostic radiographic procedures because rendering is inherent to those services.

    Breast CT, including 3D rendering for all indications, is experimental and investigational.

    3D, 4D, or 5D obstetrical ultrasound is experimental, investigational, and unproven.

    Use of 3D rendering for a condition or diagnosis listed in the coverage indications is not medically necessary when the applicable coverage criteria are not met.

    3D rendering is not medically necessary when the needed clinical information can be obtained through traditional 2D imaging, including ultrasound, CT, or MRI.

    3D rendering is not medically necessary when it accompanies an imaging study that is itself not medically necessary or investigational.

    Covered Clinical Indications

    Musculoskeletal Conditions

    Coverage applies when at least one of the following musculoskeletal indications is present:

    Musculoskeletal indications

    • Congenital skull abnormalities: Evaluation of congenital skull abnormalities in newborns, infants, or toddlers, usually for preoperative planning.
    • Complex joint or pelvic fractures: Evaluation of complex joint fractures or pelvic fractures.
    • Spine fractures: Evaluation of spine fractures, usually for preoperative planning.
    • Complex facial fractures:

    Provider Documentation and Billing Actions

    Prior Authorization

    Check Plan Requirements

    Review the member’s contract and endorsements before providing 3D rendering to identify applicable exclusions, prior authorization requirements, and benefit limitations.

    Documentation Required

    Submit a Standard Written Order

    Submit a Standard Written Order prescribed by a qualified healthcare provider concerning the member’s diagnosis.

    Documentation Required

    Support Medical Necessity

    Provide medical records supporting medical necessity and the need for 3D rendering or reconstruction, including continued need or use when applicable. Documentation should include clinical evaluation or preoperative planning, explain how the rendering is critical to clinical management, and explain why traditional 2D imaging would not be useful.

    Authorization Requirements

    Prior Authorization

    Verify plan-specific authorization

    Review the member’s contract and endorsements to determine whether prior authorization, exclusions, or other benefit requirements apply to CT, MRI, or ultrasound 3D rendering.

    Excluded and Noncovered Applications

    The following are not covered under this guideline: breast CT, including 3D rendering for all indications; 3D, 4D, or 5D obstetrical ultrasound; and 3D rendering used with MRA, CTA, nuclear medicine SPECT, PET, PET/CT, mammography, breast MRI, breast ultrasound, breast tomosynthesis, CT colonography, cardiac MRI, cardiac CT, coronary CTA, bronchoscopy, nuclear medicine thyroid uptake, physician-planned patient-specific aortic endograft procedures, or unlisted diagnostic radiographic procedures when rendering is inherent to the associated service.

    Clinical Background

    3D rendering reconstructs multiple thin image sections into images that convey the three-dimensional relationships of structures and may improve visualization of pathology. It may be performed on the original scanner or through post-processing on an independent workstation, sometimes requiring extensive physician and specially trained technologist processing.

    Key Definitions

    3D rendering
    DefinitionA process that uses multiple thin sections of images to reconstruct 3D images displaying anomalies or structures and enhancing visualization of pathology.
    3D reconstruction or reformation
    Alternative terms3D reconstruction; 3D reformation
    Policy Summary
    PayerWPS Health Insurance
    Policy3D Rendering on CT/MRI/US Medical Guideline
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateJuly 1, 2026
    Last ReviewApr 1, 2026
    Next Review DateNot specified
    Key ActionReview the member's contract and endorsements to determine whether prior authorization or other benefit requirements apply.
    SourceLink
    On This Page
    General Coverage CriteriaCovered Clinical IndicationsProvider Documentation and Billing ActionsAuthorization RequirementsExcluded and Noncovered ApplicationsClinical BackgroundKey Definitions
  1. MRI fusion biopsy of prostate/TRUS: MRI fusion biopsy of the prostate/transrectal ultrasound, including MRI/TRUS.
  2. Evaluation of complex facial fractures.

    Preoperative Planning

    Coverage applies for:

    Complex surgical planning: Preoperative planning for other complex surgical cases.

    Cerebral Angiography

    Coverage applies for:

    Cerebral angiography, except MRA and/or CTA, which are subject to the stated limitations of coverage.

    Echocardiography

    Coverage applies when transthoracic or transesophageal echocardiography is used for at least one of the following:

    Qualifying echocardiography use

    • Valvular disease evaluation: Evaluation of at least moderate valvular stenosis or regurgitation.at least moderate
    • Transcatheter procedure guidance: Guidance of transcatheter valve replacement, such as TAVR, mitral valve clipping or replacement, or fistula coiling.
    • LV volume and EF assessment: Assessment of left ventricular volume and ejection fraction before ICD implantation, or before or within 12 months after receiving potentially cardiotoxic chemotherapy.before or within 12 months after chemotherapy

    Ultrasound of Pelvic Conditions

    Coverage applies when at least one of the following pelvic or prostate-imaging indications is present:

    Qualifying pelvic ultrasound indications

    • Uterine intra-cavity lesion: The initial ultrasound is equivocal, or 3D ultrasound/sonohysterogram is performed instead of hysteroscopy.
    • Hydrosalpinx or peritoneal cysts: The initial ultrasound is indeterminate, or 3D ultrasound/sonohysterogram is performed instead of hysteroscopy.
    • Lost IUD: The IUD string cannot be felt or seen and the initial ultrasound is indeterminate.
    • Uterine anomalies: The initial ultrasound is indeterminate or equivocal.
    • Infertility evaluation: The initial ultrasound is indeterminate or equivocal, or 3D ultrasound/sonohysterogram is performed instead of hysteroscopy.
    • MRI fusion biopsy of the prostate/TRUS: MRI fusion biopsy of the prostate/transrectal ultrasound, including MRI/TRUS.

    Abdominal Conditions

    Coverage applies for:

    MRCP: Magnetic resonance cholangiopancreatography is performed for assessment of the biliary tree.

    MRCP means magnetic resonance cholangiopancreatography.

    Billing Rule

    Use Correct Coding

    Use correct coding for the service and comply with generally accepted coding guidelines.

    • Do not separately submit 3D rendering with services for which rendering is inherent, including CAD, MRA, CTA, nuclear medicine SPECT, PET or PET/CT, mammography, breast MRI or ultrasound, breast tomosynthesis, CT colonography, cardiac MRI or CT, coronary CTA, bronchoscopy, nuclear medicine thyroid uptake, physician-planned patient-specific aortic endograft, or unlisted diagnostic radiographic procedures.
    Denial Risk

    Criteria Not Met or 2D Imaging Is Sufficient

    Do not submit 3D rendering as medically necessary when the applicable coverage criteria are not met or when the needed information can be obtained through traditional 2D imaging, such as ultrasound, CT, or MRI. Rendering is also not medically necessary when used with an imaging study that is itself not medically necessary or is experimental, investigational, or unproven.

    • For a listed condition or diagnosis, failure to meet the applicable criteria makes 3D rendering not medically necessary.
    • For a condition or diagnosis not listed in the indications of coverage, the use is experimental, investigational, and unproven.
    Denial Risk

    Unlisted Diagnosis or Condition

    Use for an unlisted condition or diagnosis is considered experimental, investigational, and unproven to affect health outcomes.

    Denial Risk

    Breast CT Excluded

    Breast CT, including 3D rendering for all indications, is considered experimental and investigational.

    Denial Risk

    Obstetrical Ultrasound Excluded

    Three-dimensional, four-dimensional, and five-dimensional obstetrical ultrasound is considered experimental, investigational, and unproven.

    Billing Rule

    Rendering Inherent to Another Service

    Do not separately submit 3D rendering when it is inherent to an associated procedure or imaging study under generally accepted coding guidelines; the rendering may not be payable as a separate service.

    • Examples include CAD, MRA, CTA, nuclear medicine SPECT, PET, PET/CT, mammography, breast MRI or ultrasound, breast tomosynthesis, CT colonography, cardiac MRI or CT, coronary CTA, bronchoscopy, nuclear medicine thyroid uptake, physician-planned patient-specific aortic endograft, and unlisted diagnostic radiographic procedures.